These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 19630712)

  • 1. Policy and health implications of using the U.S. Food and Drug Administration product design approach in reducing tobacco product risk.
    Givel M
    Curr Drug Abuse Rev; 2008 Jun; 1(2):135-41. PubMed ID: 19630712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Making big tobacco give in: you lose, they win.
    Wander N; Malone RE
    Am J Public Health; 2006 Nov; 96(11):2048-54. PubMed ID: 17018823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No sisyphean task: how the FDA can regulate electronic cigarettes.
    Paradise J
    Yale J Health Policy Law Ethics; 2013; 13(2):326-74. PubMed ID: 24340824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The need for FDA regulation of tobacco products.
    Kennedy EM
    Yale J Health Policy Law Ethics; 2002; 3(1):101-8. PubMed ID: 12825428
    [No Abstract]   [Full Text] [Related]  

  • 5. In search of the less hazardous cigarette.
    Givel M
    Int J Health Serv; 2011; 41(1):77-94. PubMed ID: 21319722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tobacco company efforts to influence the Food and Drug Administration-commissioned Institute of Medicine report clearing the smoke: an analysis of documents released through litigation.
    Tan CE; Kyriss T; Glantz SA
    PLoS Med; 2013; 10(5):e1001450. PubMed ID: 23723740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of smokeless tobacco product marketing and use on population harm from tobacco use policy perspective for tobacco-risk reduction.
    Kozlowski LT
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S379-86. PubMed ID: 18021913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Has the tobacco industry evaded the FDA's ban on 'Light' cigarette descriptors?
    Connolly GN; Alpert HR
    Tob Control; 2014 Mar; 23(2):140-5. PubMed ID: 23485704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. US Smokers' Beliefs, Experiences and Perceptions of Different Cigarette Variants Before and After the FSPTCA Ban on Misleading Descriptors Such as "Light," "Mild," or "Low".
    Yong HH; Borland R; Cummings KM; Lindblom EN; Li L; Bansal-Travers M; O'Connor RJ; Elton-Marshall T; Thrasher JF; Hammond D; Thompson ME; Partos TR
    Nicotine Tob Res; 2016 Nov; 18(11):2115-2123. PubMed ID: 27083215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The "global settlement" with the tobacco industry: 6 years later.
    Givel M; Glantz SA
    Am J Public Health; 2004 Feb; 94(2):218-24. PubMed ID: 14759930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A global approach to tobacco policy.
    Gray N
    Lung Cancer; 2003 Feb; 39(2):113-7. PubMed ID: 12581561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research opportunities related to establishing standards for tobacco products under the Family Smoking Prevention and Tobacco Control Act.
    Hecht SS
    Nicotine Tob Res; 2012 Jan; 14(1):18-28. PubMed ID: 21324834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marketing 'less harmful, low-tar' cigarettes is a key strategy of the industry to counter tobacco control in China.
    Yang G
    Tob Control; 2014 Mar; 23(2):167-72. PubMed ID: 23349230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDA's misplaced priorities: premarket review under the Family Smoking Prevention and Tobacco Control Act.
    Jenson D; Lester J; Berman ML
    Tob Control; 2016 May; 25(3):246-53. PubMed ID: 27068243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of and beliefs about light cigarettes in four countries: findings from the International Tobacco Control Policy Evaluation Survey.
    Borland R; Yong HH; King B; Cummings KM; Fong GT; Elton-Marshall T; Hammond D; McNeill A
    Nicotine Tob Res; 2004 Dec; 6 Suppl 3():S311-21. PubMed ID: 15799594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obsolete tobacco control themes can be hazardous to public health: the need for updating views on absolute product risks and harm reduction.
    Kozlowski LT; Abrams DB
    BMC Public Health; 2016 May; 16():432. PubMed ID: 27221096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Will the next generation of "safer" cigarettes be safer?
    Warner KE
    J Pediatr Hematol Oncol; 2005 Oct; 27(10):543-50. PubMed ID: 16217258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons from the history of tobacco harm reduction: The National Cancer Institute's Smoking and Health Program and the "less hazardous cigarette".
    Parascandola M
    Nicotine Tob Res; 2005 Oct; 7(5):779-89. PubMed ID: 16191749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Permissive nicotine regulation as a complement to traditional tobacco control.
    Sumner W
    BMC Public Health; 2005 Feb; 5():18. PubMed ID: 15730554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health impact of "reduced yield" cigarettes: a critical assessment of the epidemiological evidence.
    Thun MJ; Burns DM
    Tob Control; 2001; 10 Suppl 1(Suppl 1):i4-11. PubMed ID: 11740038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.